BackAmryt Pharma Plc Overview

Amryt Pharma Plc Total Liabilities

Track Amryt Pharma Plc's total liabilities ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$0.00
100.00% YoYΔ $-440.88M vs prior year quarter

Peer average

Loading

Amryt Pharma Plc Total Liabilities History

Loading

Amryt Pharma Plc vs. peers: Total Liabilities Comparison

Loading

Amryt Pharma Plc Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Amryt Pharma Plc (AMYT) FAQ

As of the most recent data (April 2023), AMYT shows a total liabilities of $0. That compares with $440M in the prior-year period — down 100.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, AMYT's total liabilities is now $0 (was $440M) — a 100.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Amryt Pharma Plc is outperforming or lagging.

Tracking AMYT's total liabilities over time shows whether Amryt Pharma Plc is scaling, shrinking, or reshaping that part of the business. The current reading is $0 That compares with $440M in the prior-year period — down 100.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has Amryt Pharma Plc's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $0) with ownership activity and broader fundamentals.

Amryt Pharma Plc's total liabilities is $0; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.